Send us a text In this episode, I continue reading from a review titled “The Multifaceted Benefits of Walking for Healthy Aging: From Blue Zones to Molecular Mechanisms," a "comprehensive summary of the extensive literature on the health benefits of walking in older adults." In Part One, we reviewed the methods of this study and the cardiovascular outcomes, including hypertension and cardiovascular and cerebrovascular diseases. In Part Two we will cover Cognitive Function and Dementia, Type 2...
All content for Why Walking Matters: The Science Explained is the property of Tatyana Simms and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text In this episode, I continue reading from a review titled “The Multifaceted Benefits of Walking for Healthy Aging: From Blue Zones to Molecular Mechanisms," a "comprehensive summary of the extensive literature on the health benefits of walking in older adults." In Part One, we reviewed the methods of this study and the cardiovascular outcomes, including hypertension and cardiovascular and cerebrovascular diseases. In Part Two we will cover Cognitive Function and Dementia, Type 2...
Read from: Prevention Magazine April 2024 Feeling overwhelmed? You’re not alone — and you don’t have to stay stuck. In this episode, we explore how something as simple as a daily walk can reduce stress levels, calm your nervous system, and boost your mental clarity. Backed by science and easy to implement, these small steps could lead to big relief. Lace up, press play, and walk it off — literally.
Why Walking Matters: The Science Explained
Send us a text In this episode, I continue reading from a review titled “The Multifaceted Benefits of Walking for Healthy Aging: From Blue Zones to Molecular Mechanisms," a "comprehensive summary of the extensive literature on the health benefits of walking in older adults." In Part One, we reviewed the methods of this study and the cardiovascular outcomes, including hypertension and cardiovascular and cerebrovascular diseases. In Part Two we will cover Cognitive Function and Dementia, Type 2...
